Work

Adjuvant nivolumab fails to improve disease‐free survival in patients with resected NSCLC

Year: 2026
Type: article
Abstract: Perioperative apalutamide plus ADT presents a new option for high-risk localized prostate cancer
Source: Cancer
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7233030758
FWCI:
Cites: 6
Cited by:
Related to: 10